Additionally, it suppresses glucagon secretion , a hormone that raises blood sugar levels, thereby preventing excessive glucose production by the liver
NICE technology appraisal TA875 (2023) recommends Wegovy within a specialist weight management service for adults with a BMI of 35 kg/m or above (or 30 kg/m in certain high-risk groups) and at least one weight-related health condition, for a maximum of two years
Milder Side Effects (Potentially): The gradual release of a smaller dose may result in fewer and milder side effects compared to injections, although individual experiences can vary
Step 2: Personalized treatment planning Dosage guidance and lifestyle considerations are aligned to support tolerance and consistency
27 Dapagliflozin (10 mg for 12 weeks) significantly reduced intrahepatic lipid content and ALT in patients with T2DM
Or tirzepatide appetite effects , which many users describe as life-changing